L908-0193 Screening compound: N~1~-(3-chloro-4-fluorophenyl)-2-[2-oxo-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-3(2H)-yl]acetamide

L908-0193 Screening compound: N~1~-(3-chloro-4-fluorophenyl)-2-[2-oxo-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-3(2H)-yl]acetamide
L908-0193 Screening compound: N~1~-(3-chloro-4-fluorophenyl)-2-[2-oxo-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-3(2H)-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L908-0193
N~1~-(3-chloro-4-fluorophenyl)-2-[2-oxo-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-3(2H)-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L908-0193

Molecular Formula

C19H15ClFN5O2S (C19 H15 ClFN5 O2 S)

Compound Name

N~1~-(3-chloro-4-fluorophenyl)-2-[2-oxo-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-3(2H)-yl]acetamide

IUPAC name

N-(3-chloro-4-fluorophenyl)-2-{4-oxo-10-thia-3568-tetraazatetracyclo[7.7.0.0^{26}.0^{1116}]hexadeca-1(9)2711(16)-tetraen-5-yl}acetamide

SMILES

O=C(CN1N(C=Nc2c3c(CCCC4)c4s2)C3=NC1=O)Nc(cc1)cc(Cl)c1F

InChI

InChI=1S/C19H15ClFN5O2S/c20-12-7-10(5-6-13(12)21)23-15(27)8-25-19(28)24-17-16-11-3-1-2-4-14(11)29-18(16)22-9-26(17)25/h5-7,9H,1-4,8H2,(H,23,27)

InChI Key

PXTNOQXAKSCVBF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27485818

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.88

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.888

Distribution Coefficient, logD

0.269

Water Solubility, LogSw

-4.67

Polar Surface Area

60.941

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

10.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

L908-0193 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L908-0193 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L908-0193?
Check Price and Availability of L908-0193, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L908-0193 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L908-0193
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L908-0193
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L908-0193 available by request